Thomas D Szucs

Ontology type: schema:Person     

Person Info


Thomas D



Publications in SciGraph latest 50 shown

  • 2017-08-11 Regulatory watch: Structural and procedural characteristics of international regulatory authorities in NATURE REVIEWS DRUG DISCOVERY
  • 2017-07 The enigma of value: in search of affordable and accessible health care in THE EUROPEAN JOURNAL OF HEALTH ECONOMICS
  • 2015-12 Cost Effectiveness of Sucroferric Oxyhydroxide Compared with Sevelamer Carbonate in the Treatment of Hyperphosphataemia in Patients Receiving Dialysis, from the Perspective of the National Health Service in Scotland in PHARMACOECONOMICS
  • 2015-07 Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients in BREAST CANCER RESEARCH AND TREATMENT
  • 2015-03 Regulatory watch: Efficiency indicators for new drugs approved by the FDA from 2003 to 2013 in NATURE REVIEWS DRUG DISCOVERY
  • 2015-03 Trends in incidence and medical resource utilisation in patients with chronic lymphocytic leukaemia: insights from the UK Clinical Practice Research Datalink (CPRD) in ANNALS OF HEMATOLOGY
  • 2015-02 Cost-Effectiveness Analysis of Prognostic Gene Expression Signature-Based Stratification of Early Breast Cancer Patients in PHARMACOECONOMICS
  • 2014-12 Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related and genetic risk factors in BMC CANCER
  • 2014-12 Delivery of health care at the end of life in cancer patients of four swiss cantons: a retrospective database study (SAKK 89/09) in BMC CANCER
  • 2014-10 Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel in BREAST CANCER RESEARCH AND TREATMENT
  • 2014-08 The use of the EVITA algorithm for clinical assessment of novel agents used in prostate cancer, metastatic melanoma, and systemic lupus erythematosus in EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
  • 2014-06 Using the EuroQol EQ-5D in Swiss Cancer Patients, Which Value Set Should be Applied? in PHARMACOECONOMICS
  • 2013-12 Self-reported headache among the employees of a Swiss university hospital: prevalence, disability, current treatment, and economic impact in THE JOURNAL OF HEADACHE AND PAIN
  • 2013-12 Identifying patients with chronic conditions using pharmacy data in Switzerland: an updated mapping approach to the classification of medications in BMC PUBLIC HEALTH
  • 2013-03 The Economic Burden of Depression in Switzerland in PHARMACOECONOMICS
  • 2013-02 A Systematic Review of the Cost Effectiveness of Herpes Zoster Vaccination in PHARMACOECONOMICS
  • 2012-01 Personalized cancer medicine and the future of pathology in VIRCHOWS ARCHIV
  • 2011-12 Determining utility values in patients with anterior cruciate ligament tears using clinical scoring systems in BMC HEALTH SERVICES RESEARCH
  • 2011-12 Reconstruction versus conservative treatment after rupture of the anterior cruciate ligament: cost effectiveness analysis in BMC HEALTH SERVICES RESEARCH
  • 2011-12 Diagnostic accuracy of point-of-care testing for acute coronary syndromes, heart failure and thromboembolic events in primary care: a cluster-randomised controlled trial in BMC FAMILY PRACTICE
  • 2011-04 Risk factors for chemotherapy-induced neutropenia occurrence in breast cancer patients: data from the INC-EU Prospective Observational European Neutropenia Study in SUPPORTIVE CARE IN CANCER
  • 2011-04 Predictors of family communication of one’s organ donation intention in Switzerland in INTERNATIONAL JOURNAL OF PUBLIC HEALTH
  • 2010-12 Cost-effectiveness of oral alitretinoin in patients with severe chronic hand eczema - a long-term analysis from a Swiss perspective in BMC DERMATOLOGY
  • 2010-12 A cross-sectional survey to evaluate knowledge, attitudes and practices (KAP) regarding seasonal influenza vaccination among European travellers to resource-limited destinations in BMC PUBLIC HEALTH
  • 2010-12 Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery in JOURNAL OF HEMATOLOGY & ONCOLOGY
  • 2010-11 Human epidermal growth factor receptor 2 expression in early breast cancer patients: a Swiss cost–effectiveness analysis of different predictive assay strategies in BREAST CANCER RESEARCH AND TREATMENT
  • 2010-08 Cost Effectiveness of Cytotoxic and Targeted Therapy for Metastatic Breast Cancer in PHARMACOECONOMICS
  • 2010-02 Cost-effectiveness of antihypertensive treatment in patients 80 years of age or older in Switzerland: an analysis of the HYVET study from a Swiss perspective in JOURNAL OF HUMAN HYPERTENSION
  • 2009-10 Disparities in influenza vaccination coverage rates by target group in five European countries: Trends over seven consecutive seasons in INFECTION
  • 2009-06 Agreement of Swiss-Adapted International and European Guidelines for the Assessment of Global Vascular Risk and for Lipid Lowering Interventions in CARDIOVASCULAR DRUGS AND THERAPY
  • 2009-06 Reducing the Burden of Influenza-Associated Complications with Antiviral Therapy in INFECTION
  • 2009 Is Cancer Prevention Ever Going to Be Profitable? in CANCER PREVENTION II
  • 2008-12 Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons in BMC PUBLIC HEALTH
  • 2008-11 Trends in Influenza Vaccination Coverage Rates in Germany over Six Seasons from 2001/02 to 2006/07 in MEDIZINISCHE KLINIK
  • 2008-11 Neutropenia occurrence and predictors of reduced chemotherapy delivery: results from the INC-EU prospective observational European neutropenia study in SUPPORTIVE CARE IN CANCER
  • 2008-10 Influenza vaccination coverage rates in Austria in 2006/07 – a representative cross-sectional telephone survey in WIENER MEDIZINISCHE WOCHENSCHRIFT
  • 2008-07 Kosteneffektivität einer Osteoporose-Behandlung nach systematischem Bevölkerungsscreening in der Schweiz: Auswirkungen der Preisreduktion des Alendronat-Originalpräparates in PHARMACOECONOMICS GERMAN RESEARCH ARTICLES
  • 2008-01 Kosten-Nutzen-Effektivität von Clopidogrel bei akutem Koronarsyndrom in HERZ
  • 2007-12 Trends in influenza vaccination coverage rates in Germany over five seasons from 2001 to 2006 in BMC INFECTIOUS DISEASES
  • 2007-10 Influenza Vaccination Coverage Rates in 5 European Countries: a Population-Based Cross-Sectional Analysis of the Seasons 02/03, 03/04 and 04/05 in INFECTION
  • 2007-10 Determinants of Costs and the Length of Stay in Acute Coronary Syndromes: A Real Life Analysis of More Than 10 000 Patients in CARDIOVASCULAR DRUGS AND THERAPY
  • 2006-09 Neutropenic event risk and impaired chemotherapy delivery in six European audits of breast cancer treatment in SUPPORTIVE CARE IN CANCER
  • 2006-08 Healing Unhealthy Hungarian Hearts – At What Cost? – With What Benefit? in CARDIOVASCULAR DRUGS AND THERAPY
  • 2006-07 Grippeimpfung in Deutschland in MEDIZINISCHE KLINIK
  • 2006-06 Cost-Effectiveness of Eplerenone in Patients with Left Ventricular Dysfunction after Myocardial Infarction—An Analysis of the EPHESUS Study from a Swiss Perspective in CARDIOVASCULAR DRUGS AND THERAPY
  • 2005-10 Economic Impact of Hyperhomocysteinemia in Switzerland in CARDIOVASCULAR DRUGS AND THERAPY
  • 2005-08 Pharmacotherapy of Acute Coronary Syndromes: Medical Economics with an Emphasis on Clopidogrel in CARDIOVASCULAR DRUGS AND THERAPY
  • 2005-06 A model of osteoporosis impact in Switzerland 2000–2020 in OSTEOPOROSIS INTERNATIONAL
  • 2005-04 Meningococcal vaccination: Cui bono? in PHARMACOECONOMICS
  • 2005-02 Medizinische Ökonomie in der Onkologie in DER ONKOLOGE
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

        "@context": "", 
        "affiliation": [
            "affiliation": {
              "id": "", 
              "type": "Organization"
            "isCurrent": true, 
            "type": "OrganizationRole"
            "id": "", 
            "type": "Organization"
            "id": "", 
            "type": "Organization"
            "id": "", 
            "type": "Organization"
            "id": "", 
            "type": "Organization"
        "familyName": "Szucs", 
        "givenName": "Thomas D", 
        "id": "sg:person.01365717307.36", 
        "sameAs": [
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T14:52", 
        "sdLicense": "", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_588.json", 
        "type": "Person"

    Download the RDF metadata as:  json-ld nt turtle xml License info


    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' ''

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' ''

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' ''

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' ''


    This table displays all metadata directly associated to this object as RDF triples.

    24 TRIPLES      10 PREDICATES      15 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.01365717307.36 schema:affiliation N88a348f35ab94cf181e2db3e4cc93955
    6 schema:familyName Szucs
    7 schema:givenName Thomas D
    8 schema:sameAs
    9 schema:sdDatePublished 2019-03-07T14:52
    10 schema:sdLicense
    11 schema:sdPublisher N9eaea49695bd4e8a954c3cb522383d61
    12 sgo:license sg:explorer/license/
    13 sgo:sdDataset persons
    14 rdf:type schema:Person
    15 N88a348f35ab94cf181e2db3e4cc93955 schema:affiliation
    16 sgo:isCurrent true
    17 rdf:type schema:OrganizationRole
    18 N9eaea49695bd4e8a954c3cb522383d61 schema:name Springer Nature - SN SciGraph project
    19 rdf:type schema:Organization
    20 schema:Organization
    21 schema:Organization
    22 schema:Organization
    23 schema:Organization
    24 schema:Organization

    Preview window. Press ESC to close (or click here)